Helical tomotherapy
By Rudolf Schwarz and Andreas Krüll, of the Section of Radiation Oncology Department, Ambulanzzentrum GmbH of the University Medical Center Hamburg-Eppendorf
Therapy
MR probes for molecular imaging
Molecular imaging aims at the in vivo quantitative visualisation of molecules and molecular events that occur at cellular level. The potential towards clinical translation is huge, because the same modalities used in medical imaging are used in molecular imaging investigations.
How to achieve tight glucose control
By Professor Jean-Charles Preiser MD PhD, of the Department of General Intensive Care, University Hospital Centre, University of Liege, Belgium
Open High-field MRI
As part of a research and development project, doctors at the University Hospital Magdeburg, Germany, are treating oncology patients with local minimally invasive surgery (MIS) which, for the first time, can be carried out under radiological image control using high-field magnetic resonance imaging (MRI). The system offers excellent image quality under extremely favourable, radiation-free…
New Optical Breast Imaging System
Advanced Research Technologies Inc. ("ART") announced the first sale of SoftScan® optical breast imaging system to the Sunnybrook Health Sciences Centre ('Sunnybrook") in Toronto, Canada. Sunnybrook is the first health centre to purchase a SoftScan imaging system since the Canadian company received regulatory approval for commercialization in Europe and Canada for its optical breast imaging…
New system speeds-up UGI cancer diagnosis and treatment
The upper gastrointestinal (UGI) team at Milton Keynes Hospital NHS Foundation Trust has developed a rapid access service for upper gastrointestinal cancers. The new system means that patients are referred directly from their GP to the hospital for an endoscopy.
Computerised model of the heart to develop new therapies
During a workshop organized by the European Science Foundation (ESF), researchers discussed further steps in developing computerised “in-silico” models of the heart that simulate the real heart and enable possible drugs and therapies to be tested without risk to people.
COPD: New therapy reduces mortality
Patients with severe COPD may benefit more from therapy that combines salmeterol and fluticasone [SFC] than treatment with tiotropium, according to results from a long-term, multi-center study, “Investigating New Standards for Prophylaxis in Reducing Exacerbations” (INSPIRE) that directly compared the two therapies.
Neuroendocrine Cancer
The collaboration between two companies may pave the way for the development of new therapy options for neuroendocrine tumors: Covidien LTd, a global provider of healthcare products and BioSynthema Inc., a company specialized in the discovery and development of molecular targeted biophamaceuticals recently signed an agreement that will gain BioSynthema access to specific Covidien proprietary…
CLINICIP
Presented during a symposium at Langenbeck-Virchow-Haus, in Berlin, the European CLINICIP research project aims to develop a method to improve glycaemic control during intensive care and provide a low-risk monitoring and control system that can control the metabolism of the critically ill
A new scientific association promotes use in mainstream medicine
Enzymes are biocatalysts that control the different metabolic processes of living organisms. These range from digestion to the copying of genetic information.
The optical biopsy: Coming into view?
A British collaboration has secured £325,000 (?460,000) of government backing to develop an in vivo optical imaging probe for diagnostic and therapeutic applications in oncology. The long-term objective is to use optical coherence tomography (OCT), an interferometric imaging modality, to perform real-time diagnosis and to guide the removal of cancerous or precancerous tissue during the same…
Successful OCT imaging during cancer surgery
UK - Optical imaging company Michelson Diagnostics Ltd (MDL) has announced successful initial results from clinical testing of its novel optical coherence tomography (OCT) imaging technology. The tests, performed on cancerous and precancerous human oesophagus and lymph node tissue, were designed to establish the potential value of MDL's optical imaging technology used during cancer surgery.
Nutrition and health
In Europe, more than ten million people suffer from diabetes mellitus, 90 percent of whom have diabetes type II.
Optical molecular imaging
Carestream's molecular imaging group focuses on life sciences, developing high-performance digital imaging systems, imaging agents, film and accessories for the research and drug discovery/development markets.
Euro 900 million for molecular imaging R&D
The Technology initiative “Molecular Imaging” aims to strengthen the synergies of science and industry in research and development of new technologies in order to significantly improve diagnostic and treatment options, for example for cardiovascular diseases, cancer or Alzheimer's.
World premiere at MEDICA
Over 15 million people are affected by strokes annually, and about five million of these (source: WHO 2004) are left with lasting damage.
E-psychiatry
The uses of the internet in psychiatry have increased in recent years, and there is evidence that professionals, patients, families, institutions and other agents benefit from it.
Embracing Excellence in Prostate and Kidney Cancer
The first European Multidisciplinary Meeting on Urological Cancers will take place in Barcelona, Spain, November 2nd to 4th, 2007. The meeting is co-organized by the European Association of Urology (EAU), the European Society for Medical Oncology (ESMO) and the European Society for Therapeutic Radiology and Oncology (ESTRO).
Effectiveness of multidrug combinations for chemotherapy
Professor Loennidis, University of Ioannina School of Medicine, Greece, and a team of researchers examined 242 randomized trials, performed during the last fourty years and covering the efficiacy of chemotherapy treatment for advanced stages of colorectal cancer. The scientist compared the benefits and outcome of different systemic treatment regimes.
Stem Cell therapy repairs lungs in mice
At the Annual Congress of the European Respiratory Society (ERS), which took place in Stockholm, September 15-19, 2007, researchers from the Imperial College London, UK, presented their study about the successful implantation of lung cells grown from embryonic stem cells into the lungs of mice. In future, this method could be used for the treatment of human lung diseases.
The therapeutic potential of adult stem cells in cardiovascular diseases
By Bodo E. Strauer (Düsseldorf, Germany) Russian summary and complete article in English.
Progenitor Cell Transfer to Repair the Heart after Myocardial Infarction
By Stefan P. Janssens, MD, PhD Russian summary and complete article in English.
Cardiologists meet to sum up progress
During a meeting of cardiologists in Prague earlier this year to exchange experiences with new methods and treatments to control atrial fibrillation, Dr Josef Kautzner, Head of Cardiology Department at IKEM (Institute of Clinical and Experimental Medicine) pointed out that numbers of patients with AF will more than double during the next 20 years.
Cardiac resynchronisation therapy
Switzerland - A clinical trial of cardiac resynchronisation therapy (CRT) in patients with advanced heart failure and a narrow QRS complex
